AP BIOLOGY

Detailed explanation-1: -Hybridoma technology is one of the most common methods used to produce monoclonal antibodies. In this process, antibody-producing B lymphocytes are isolated from mice after immunizing the mice with specific antigen and are fused with immortal myeloma cell lines to form hybrid cells, called hybridoma cell lines.

Detailed explanation-2: -The traditional monoclonal antibody (mAb) production process usually starts with generation of mAb-producing cells (i.e. hybridomas) by fusing myeloma cells with desired antibody-producing splenocytes (e.g. B cells). These B cells are typically sourced from animals, usually mice.

Detailed explanation-3: -Fusion with a tumor cell to make the hybridoma, result in the production of monoclonal antibodies against the specific virus. The hybridoma cells are placed into media that can help them grow and produce the bulk quantities of monoclonal antibodies.

Detailed explanation-4: -Formation of monoclonal antibodies The spleen cells are fused with human cancerous white blood cells called myeloma cells to form hybridoma cells which divide indefinitely. These hybridoma cells divide and produce millions of monoclonal antibodies specific to the original antigen.

Detailed explanation-5: -Hybridoma is a culture of hybrid cells that results from the fusion of B cells and myeloma cells. Hybridoma technology produces hybridomas. This technology was developed to produce mAbs. Hybridomas possess two important properties of B cells, production of antibodies, and immortalization of myeloma cells.